SARS‐CoV‐2 Vaccine Response in Lung Transplant Recipients: A French Multicenter Study

PURPOSE: Many scientific societies recommend SARS‐CoV‐2 vaccination for solid-organ transplant recipients. The immunogenicity of two or three vaccine doses in lung transplant (LTx) recipients is unclear. The aim of this study was to evaluate the humoral response to the vaccine in LTx and heart-lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Dauriat, G., Beaumont, L., Renaud-Picard, B., Salpin, M., Coiffard, B., Danner-Boucher, I., Leborgne, A., Feuillet, S., Penhouet, M., Reynaud-Gaubert, M., Gallais, F., Messika, J., Roux, A., Pavec, J. Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
(237)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988560/
http://dx.doi.org/10.1016/j.healun.2022.01.258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988560/
http://dx.doi.org/10.1016/j.healun.2022.01.258

Ejemplares similares